港股生物科技股集体上涨，北海康成-B涨近19%，贝康医疗涨超7%

Group 1 - The Hong Kong biotechnology stocks experienced a collective increase, with Beihai Kangcheng-B rising nearly 19% [1] - Gilead Sciences-B surged over 15%, while Ascentage Pharma-B increased by more than 9% [1] - Other notable gainers include Jiahe Biopharma-B up over 8%, and Beikang Medical-B, Fuhong Hanlin, and Kangnuo Ya-B each rising over 7% [1] Group 2 - Huakang Biomedical, Basilea Pharmaceutica-B, Lepu Biopharma-B, and Hualing Pharmaceutical-B all saw increases of over 6% [1] - Yiming Anke-B, Nocera Health, Zai Lab, and CanSino Biologics rose by more than 5% [1]